Patents by Inventor Jean-Francois Desconclois

Jean-Francois Desconclois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6566362
    Abstract: Benzo[f]naphthyridine derivatives of formula (I): benzo[f]naphthyridine derivatives and benzo[f]naphthyridine esters of formula (IVa): aminoquinoline derivatives of formula (X): processes for preparing such compounds; and compositions comprising them.
    Type: Grant
    Filed: December 31, 2001
    Date of Patent: May 20, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-François Desconclois, Arielle Genevois-Borella, Philippe Girard, Michel Kryvenko, Marc Pierre Lavergne, Jean-Luc Malleron, Guy Picaut, Michel Tabart, Sylvie Wentzler
  • Patent number: 6548506
    Abstract: Novel 1,8-benzo-naphthyridine derivatives of general formula (I): which are useful as antimicrobial agents.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: April 15, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-François Desconclois, Guy Picaut, Philippe Girard, Michel Tabart, Sylvie Wentzler
  • Publication number: 20020137741
    Abstract: Benzo[f]naphthyridine derivatives of formula (I): 1
    Type: Application
    Filed: December 31, 2001
    Publication date: September 26, 2002
    Inventors: Jean-Francois Desconclois, Arielle Genevois-Borella, Philippe Girard, Michel Kryvenko, Marc Pierre Lavergne, Jean-Luc Malleron, Guy Picaut, Michel Tabart, Sylvie Wentzler
  • Publication number: 20020037891
    Abstract: Novel 1,8-benzo-naphthyridine derivatives of general formula (I): 1
    Type: Application
    Filed: June 20, 2001
    Publication date: March 28, 2002
    Inventors: Jean-Francois Desconclois, Guy Picaut, Philippe Girard, Michel Tabart, Sylvie Wentzler
  • Patent number: 5556861
    Abstract: This invention relates to a novel 1,8 benzo[b]naphythyridine derivative of general formula (I), ##STR1## wherein R is H or a hydroxy, amino or alkylamino radical optionally substituted by amino or hydroxy, or R is dialkylamino of which the alkyl portions may form, with the nitrogen atom, a 5- or 6-membered heterocyclic ring which optionally contains a further heteroatom chosen from nitrogen, oxygen or sulphur, or R is C.sub.3-6 cycloalkylamino or an alkanylamino, N-alkyl N-alkanylamino or aminoalkylphenylamino radical; R.sub.1 and R.sub.2, which are the same or different, are in positions 2 and 3 and represent H, alkyl, C.sub.2-4 alkenyl, phenyl, or substituted phenyl, or R.sub.1 and R.sub.2 are in position 2 and represent alkyl; R.sub.3 is H or alkyl, fluoroalkyl, carboxyalkyl, C.sub.3-6 cycloalkyl, fluorophenyl, difluorophenyl, alkyloxy or alkylamino; and R.sub.4 is H or F, wherein the C.sub.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 17, 1996
    Assignee: Laboratoire Roger Bellon
    Inventors: Eric Bacque, Michel Barreau, Jean-Francois Desconclois, Philippe Girard, Michel Kryvenko, Marc P. Lavergne, Jean-Marc Paris, Guy Picaut
  • Patent number: 5053509
    Abstract: New benzo[b][1,8]naphthyridine derivatives of general formula (I), in which R.sub.1 is a hydrogen atom or a hydroxyl or alkyl radical, R.sub.2 is a hydrogen atom or an alkyl, fluoroalkyl, cycloalkyl (3 to 6 C), alkyloxy or alkylamino radical, R.sub.3 is a phenyl or phenylalkyl radical substituted with one or more halogen atoms or alkyl, cycloalkyl (3 to 6 C), alkyloxy, cyano, amino, alkylamino, dialkylamino, alkyloxyalkyl, hydroxyalkyl, hydroxyalkyloxy, methylenedioxy, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radicals, or R.sub.3 is a heterocyclic radical, and R.sub.4 is a hydrogen atom or a fluorine atom, the alkyl radicals (1 to 4 C) being linear or branched, their salts, their preparation and compositions containing them.These new products are useful as antimicrobials, or in the treatment of AIDS.
    Type: Grant
    Filed: October 30, 1990
    Date of Patent: October 1, 1991
    Assignee: Laboratoire Roger Bellon
    Inventors: Michel Antoine, Michel Barreau, Jean-Francois Desconclois, Philippe Girard, Guy Picaut
  • Patent number: 5004745
    Abstract: New benzo[b][1,8]naphthyridine derivatives of general formula (I) in which R.sub.1 is a hydrogen atom or an alkyl or hydroxyalkyl radical, R.sub.2 is a hydrogen atom or an alkyl, fluoroalkyl, cycloalkyl (3 to 6 C), alkoxy or alkylamino radical and R.sub.3 is alkyl, R.sub.4 and R.sub.5 are different and are hydrogen or alkyl, or R.sub.3 is H, alkyl or cycloalkyl and R.sub.4 and R.sub.5 are hydrogen, R.sub.6 is hydrogen or fluorine and n is equal to 1 or 2, their salts, their preparation and the compositions which contain them.
    Type: Grant
    Filed: January 16, 1990
    Date of Patent: April 2, 1991
    Assignee: Laboratoire Roger Bellon
    Inventors: Michel Antoine, Michel Barreau, Jean-Francois Desconclois, Philippe Girard, Guy Picaut
  • Patent number: 4990515
    Abstract: New benzo[b][1,8]naphthyridine derivatives of general formula (I), in which R is a hydrogen atom or an alkyl, fluoroalkyl, cycloalkyl (3 to 6 C), alkoxy or alkylamino radical or an amine protective radical and either Hal is a fluorine, chlorine or bromine atom and R' is a hydrogen atom or Hal and R' are simultaneously fluorine atoms, their salts, their preparation and the compositions which contain them.These new products can be used as antimicrobial agents for topical application or as synthesis intermediates.
    Type: Grant
    Filed: January 16, 1990
    Date of Patent: February 5, 1991
    Assignee: Rhone-Poulenc Sante
    Inventors: Michel Antoine, Michel Barreau, Jean-Francois Desconclois, Philippe Girard, Guy Picaut
  • Patent number: 4970213
    Abstract: New benzo[b][1,8]naphthyridine derivatives of general formula (I) in which R is a hydrogen atom or an alkyl, fluoroalkyl, cycloalkyl (3 to 6 C), alkoxy, alkylamino or protected alkylamino radical, Hal is F, Cl or Br if R' is hydrogen, or Hal and R' are F, and Alk is an alkyl radical, and their preparation.These new products can be used as intermediates for the preparation of biologically active products.
    Type: Grant
    Filed: January 16, 1990
    Date of Patent: November 13, 1990
    Assignee: Rhone-Poulenc Sante
    Inventors: Michel Antoine, Michel Barreau, Jean-Francois Desconclois, Philippe Girard, Guy Picaut